13
Participants
Start Date
November 30, 1999
Primary Completion Date
December 31, 2004
Study Completion Date
October 31, 2009
autologous neuroblastoma vaccine
A vaccine dose of 0.3 x 108 IL-2 secreting cells/patient/injection will be used. Injections will be given twice monthly for two months, then monthly for four months, for a total of eight vaccine injections over six months.
Texas Children's Hospital, Houston
Baylor College of Medicine
OTHER
Center for Cell and Gene Therapy, Baylor College of Medicine
OTHER
Malcolm Brenner
OTHER